CVS Health (CVS) Tops Q1 EPS by 33c, Raises FY EPS Guidance
Get Alerts CVS Hot Sheet
Price: $67.77 -1.07%
EPS Growth %: -22.3%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: -22.3%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.04, $0.33 better than the analyst estimate of $1.71. Revenue for the quarter came in at $69.1 billion versus the consensus estimate of $68.29 billion.
GUIDANCE:
CVS Health sees FY2021 EPS of $7.56-$7.68, versus the consensus of $7.53.
- The Company raised its full year 2021 GAAP diluted EPS guidance range to $6.24 to $6.36 from $6.06 to $6.22 and its full year 2021 Adjusted EPS guidance range to $7.56 to $7.68 from $7.39 to $7.55 and confirmed its full year 2021 cash flow from operations guidance range of $12.0 billion to $12.5 billion.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- First Bancorp. (FBNC) Misses Q1 EPS by 2c
- Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!